|
|||||||
| |||||||
| |||||||
1 | SENATE RESOLUTION
| ||||||
2 | WHEREAS, Chemistry is essential to human life, through | ||||||
3 | applications such as agriculture, the protection of public | ||||||
4 | health, and innovative technologies that save energy and | ||||||
5 | improve quality of life; and
| ||||||
6 | WHEREAS, The products of chemistry can pose risks that, if | ||||||
7 | improperly controlled or regulated, can threaten human health | ||||||
8 | or the environment; and
| ||||||
9 | WHEREAS, The Toxic Substances Control Act (TSCA) of 1976 | ||||||
10 | was enacted by Congress to give the United States Environmental | ||||||
11 | Protection Agency the authority to require testing and to | ||||||
12 | impose restrictions on industrial chemicals produced or | ||||||
13 | imported into the United States; and
| ||||||
14 | WHEREAS, Under its TSCA authority the U.S. EPA has required | ||||||
15 | testing of chemicals that may pose a risk to the environment or | ||||||
16 | to human-health, requires reporting of substantial risks to | ||||||
17 | human health and the environment from chemicals, and can ban | ||||||
18 | the manufacture and import of those chemicals that pose such | ||||||
19 | risks; and
| ||||||
20 | WHEREAS, Advances in technology now allow the detection of | ||||||
21 | chemicals at very low levels in the environment and the human |
| |||||||
| |||||||
1 | body, at levels that until recently were unable to be detected; | ||||||
2 | and
| ||||||
3 | WHEREAS, Analytical testing has become so sophisticated | ||||||
4 | that a National Academy of Sciences/National Research Council | ||||||
5 | Committee on Human Biomonitoring has declared that tremendous | ||||||
6 | challenges surround the use of biomonitoring information | ||||||
7 | because the ability to detect chemicals in the body far exceeds | ||||||
8 | the ability to determine what such data means to public health; | ||||||
9 | and
| ||||||
10 | WHEREAS, The U.S. Centers for Disease Control has cautioned | ||||||
11 | that the mere presence of a chemical in the human body is not | ||||||
12 | an indication that the chemical causes disease; that toxicity | ||||||
13 | of a chemical is related to its dose or concentration in | ||||||
14 | addition to a person's individual susceptibility; and
| ||||||
15 | WHEREAS, Regulations on the production and import of | ||||||
16 | chemicals is best addressed at the federal level to avoid | ||||||
17 | disruptions in trade and commerce; and
| ||||||
18 | WHEREAS, TSCA provides U.S. EPA the authority and | ||||||
19 | flexibility to adapt regulatory controls on chemicals as the | ||||||
20 | science of detection and risk evolves; therefore, be it
| ||||||
21 | RESOLVED, BY THE SENATE OF THE NINETY-FIFTH GENERAL |
| |||||||
| |||||||
1 | ASSEMBLY OF THE STATE OF ILLINOIS, that the U.S. EPA and the | ||||||
2 | Congress of the United States ensure that the Toxic Substances | ||||||
3 | Control Act of 1976 provides the necessary statutory and | ||||||
4 | regulatory controls necessary to protect human health and the | ||||||
5 | environment from the risks of industrial chemicals; and be it | ||||||
6 | further
| ||||||
7 | RESOLVED, That a suitable copy of this resolution be | ||||||
8 | presented to the Majority Leader of the United States Senate, | ||||||
9 | the Minority Leader of the United States Senate, the Speaker of | ||||||
10 | the United States House of Representatives, the Minority Leader | ||||||
11 | of the United States House of Representatives, and to each | ||||||
12 | member of the Illinois Congressional delegation.
|